Pricing Log in Create free account

Bionano Genomics, Inc. (BNGO) vs Nephros Inc. (NEPH)

Bionano Genomics, Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $33.6M against $15.4M — 2.2× the size. Bionano Genomics, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 18.0×. Nephros Inc. grew revenue faster over the last twelve months: 20.4% against 10.0%. Nephros Inc. has the higher net margin (8.86% vs −106.6%) and the higher return on invested capital (14.3% vs −81.7%). Across the 18 metrics below, Nephros Inc. leads on 14 and Bionano Genomics, Inc. on 4.

Valuation

Metric BNGO NEPH Medical Instruments & Supplies median
P/E n/m 17.98 30.28
P/S 0.42 1.59 2.49
P/B 0.41 2.74 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m 15.32 14.87
EV/Sales 0.67 1.38 2.75
Earnings yield (338.71%) 5.56% 0.00%
Free cash flow yield (160.60%) (3.02%) 0.59%

Profitability

Metric BNGO NEPH Medical Instruments & Supplies median
Gross margin 47.51% 60.55% 53.60%
Operating margin (106.67%) 8.48% 1.97%
Net margin (106.58%) 8.86% 0.00%
Free cash flow margin (67.87%) (4.22%) 2.36%
Return on equity (83.56%) 16.95% 0.00%
Return on assets (52.04%) 13.39% 0.00%
Return on invested capital (81.68%) 14.29% 0.13%

Growth

Metric BNGO NEPH Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% 20.36% 8.97%
EPS growth (last fiscal year) 94.50% 1,471.43% 6.51%
Revenue growth, 5-year CAGR 27.37% 17.02% 8.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO NEPH Medical Instruments & Supplies median
Debt to equity 0.11 0.00 0.10
Current ratio 2.48 5.50 2.47
Net debt to EBITDA 1.06 (4.20) 0.97

Dividend

Metric BNGO NEPH Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric BNGO NEPH Medical Instruments & Supplies median
Market cap 15.37m 33.59m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack